Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Selection for NEDO Public Call Project: 'Verification and Validation of Safety Toward Social Implementation of Japanese Medical-Specialized LLM'
Sarah Busch, PhD, appointed as CSO of Healios NA, Inc.
Notice of Upcoming R&D Briefing on ARDS
Announcement of Changes in Management
ONE-BRIDGE Trial in ARDS - Peer-Reviewed Publication in Japan
Notice of the Nomination of Candidates for the HEALIOS K.K. Board of Directors
Notice Concerning Reduction of Capital Stock and Capital Reserves and Appropriation of Surplus
Notice of the Partial Amendments to Articles of Incorporation
FY2024 Financial Results (Material)
The Conclusion of a Master Collaboration Agreement and License Option Agreement with Akatsuki Therapeutics Inc.
Launch of Medical Materials and Equipment Division
Agreement with AND medical to Supply Culture Supernatant
Announcement of Letter of Intent with Cell Resources for the Production of Culture Supernatant
Termination of Discussions with Nobelpharma regarding the Development and Commercializing Collaboration Agreement
Status of Conditional and Time-Limited Approval Application for ARDS in Japan (Clinical Part)
Promotion of Contract Manufacturing Business by ProcellCure
(Delayed) Appointment of D.J. Skelton as an Advisor to Healios
Status of Conditional and Time-Limited Approval Application for ARDS in Japan
Announcement of Changes in Management
Healios Selected for the AMED “Project to Promote the Industrialization of Regenerative/Cell Medicine and Gene Therapy”